Form 8-K - Current report:
SEC Accession No. 0001104659-13-068031
Filing Date
2013-09-05
Accepted
2013-09-04 18:00:41
Documents
5
Period of Report
2013-08-30
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a13-19327_18k.htm 8-K 29763
2 EX-99.1 a13-19327_1ex99d1.htm EX-99.1 50175
3 EX-99.2 a13-19327_1ex99d2.htm EX-99.2 12475
4 GRAPHIC g193271moi001.jpg GRAPHIC 4759
5 GRAPHIC g193271mmi001.jpg GRAPHIC 3926
  Complete submission text file 0001104659-13-068031.txt   105928
Mailing Address 9363 TOWNE CENTRE DRIVE SUITE 200 SAN DIEGO CA 92121
Business Address 9363 TOWNE CENTRE DRIVE SUITE 200 SAN DIEGO CA 92121 (514) 337-3333
Mirati Therapeutics, Inc. (Filer) CIK: 0001576263 (see all company filings)

EIN.: 462693615 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35921 | Film No.: 131078800
SIC: 2834 Pharmaceutical Preparations